Europe Upstream Bioprocessing Market Forecast to 2030 - Regional analysis - by Product Type (Bioreactors/Fermenters, Cell Culture, Filters, Bags and Containers, and Others), Workflow (Media Preparation, Cell Culture, and Cell Separation), Usage Type (Single-use and Multi-use), and Mode (In-house and Outsourced)
The Europe upstream bioprocessing market was valued at US$ 2,581.59 million in 2022 and is expected to reach US$ 7,069.78 million by 2030; it is estimated to grow at a CAGR of 13.4% from 2022 to 20... もっと見る
※当ページの内容はウェブ更新時の情報です。
SummaryThe Europe upstream bioprocessing market was valued at US$ 2,581.59 million in 2022 and is expected to reach US$ 7,069.78 million by 2030; it is estimated to grow at a CAGR of 13.4% from 2022 to 2030.Outsourcing of Biopharmaceutical Manufacturing Drives Europe Upstream Bioprocessing Market A large number of contract development and manufacturing organizations (CDMOs) and contract manufacturing organizations (CMOs) are engaging in bioprocessing activities, which triggers the demand for bioreactors in these facilities. The strategic outsourcing of pharmaceutical manufacturing through bioprocessing allows biopharmaceutical companies to leverage external partners' expertise and advanced capabilities in upstream processes, facilitating access to specialized technologies, process optimization expertise, and scalable manufacturing capacity. By partnering with CDMOs and CMOs, biopharmaceutical firms can efficiently manage manufacturing needs, accommodate fluctuations in production demands, and focus on core research and development activities. Additionally, outsourcing offers cost efficiencies and risk mitigation by leveraging external partners' established infrastructure and regulatory-compliant facilities. Outsourcing the bioprocessing functions allows biopharmaceutical companies to focus on fostering innovation, technological advancements, and overall upstream process expansion. Thus, the outsourcing of biopharmaceutical manufacturing significantly drives the growth of the upstream bioprocessing market. Europe Upstream Bioprocessing Market Overview The Europe upstream bioprocessing market is segmented into Germany, the UK, France, Italy, Spain, and the Rest of Europe. It is expected to register a robust growth rate owing to the availability of government and private funding for research in biologics and pharmaceuticals, leading to the launch of innovative technologies. The region has various organizations and bodies that monitor the practices being carried out in the pharmaceutical industry through conferences and other events. Companies in Europe have been focusing on showcasing their products at various events to be able to strengthen their customer base and collect information regarding developments made by any other players in the region. Thus, research initiatives, innovative products, and events such as conferences benefit the upstream bioprocessing market in Europe. Europe Upstream Bioprocessing Market Revenue and Forecast to 2030 (US$ Million) Europe Upstream Bioprocessing Market Segmentation The Europe upstream bioprocessing market is segmented based on product type, workflow, usage type, mode, and country. Based on product type, the Europe upstream bioprocessing market is segmented into bioreactors/fermenters, cell culture, filters, bags and containers, and others. The bioreactors/fermenters services held the largest market share in 2022. Based on workflow, the Europe upstream bioprocessing market is categorized into media preparation, cell culture, and cell separation. The cell separation held the largest market share in 2022. Based on usage type, the Europe upstream bioprocessing market is bifurcated into single-use and multi-use. The single-use held a larger market share in 2022 Based on mode, the Europe upstream bioprocessing market is bifurcated into In-house and outsourced. The In-house held a larger market share in 2022. Based on country, the Europe upstream bioprocessing market is segmented into the UK, Germany, France, Italy, Spain, and the Rest of Europe. Germany dominated the Europe upstream bioprocessing market share in 2022. Thermo Fisher Scientific Inc, Esco Micro Pte Ltd, Cellexus International Ltd, Sartorius AG, Getinge AB, Merck KGaA, Corning Inc, and Entegris Inc are some of the leading companies operating in the Europe upstream bioprocessing market. Table of ContentsTABLE OF CONTENTS1. Introduction 1.1 The Insight Partners Research Report Guidance 1.2 Market Segmentation 2. Executive Summary 2.1 Key Insights 3. Research Methodology 3.1 Coverage 3.2 Secondary Research 3.3 Primary Research 4. Europe Upstream Bioprocessing Market Landscape 4.1 Overview 4.2 PEST Analysis 5. Europe Upstream Bioprocessing Market - Key Market Dynamics 5.1 Market Drivers 5.1.1 Commercial Use of Single-Use Bioreactors 5.1.2 Outsourcing of Biopharmaceutical Manufacturing 5.1.3 Rapid Growth of Pharmaceutical and Biotechnology Industries 5.2 Market Restraints 5.2.1 Stringent Regulatory Framework 5.3 Market Opportunities 5.3.1 Technological Advancements 5.4 Future Trends 5.4.1 Increasing Investments in R&D in Biopharmaceutical Industry 5.5 Impact of Drivers and Restraints: 6. Upstream Bioprocessing Market - Europe Analysis 7. Europe Upstream Bioprocessing Market Analysis - by Product Type 7.1 Bioreactors/Fermenters 7.1.1 Overview 7.1.2 Bioreactors/Fermenters: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million) 7.2 Cell Culture 7.2.1 Overview 7.2.2 Cell Culture: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million) 7.3 Filters 7.3.1 Overview 7.3.2 Filters: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million) 7.4 Bags and Containers 7.4.1 Overview 7.4.2 Bags and Containers: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million) 7.5 Others 7.5.1 Overview 7.5.2 Others: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million) 8. Europe Upstream Bioprocessing Market Analysis - by Workflow 8.1 Media Preparation 8.1.1 Overview 8.1.2 Media Preparation: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million) 8.2 Cell Culture 8.2.1 Overview 8.2.2 Cell Culture: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million) 8.3 Cell Separation 8.3.1 Overview 8.3.2 Cell Separation: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million) 9. Europe Upstream Bioprocessing Market Analysis - by Usage Type 9.1 Single-use 9.1.1 Overview 9.1.2 Single-use: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million) 9.2 Multi-use 9.2.1 Overview 9.2.2 Multi-use: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million) 10. Europe Upstream Bioprocessing Market Analysis - by Mode 10.1 In-house 10.1.1 Overview 10.1.2 In-house: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million) 10.2 Outsourced 10.2.1 Overview 10.2.2 Outsourced: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million) 11. Europe Upstream Bioprocessing Market - Country Analysis 11.1 Europe Market Overview 11.1.1 Europe: Upstream Bioprocessing Market - Revenue and Forecast Analysis - by Country 11.1.1.1 Europe: Upstream Bioprocessing Market - Revenue and Forecast Analysis - by Country 11.1.1.2 UK 11.1.1.3 UK: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million) 11.1.1.3.1 UK: Upstream Bioprocessing Market Breakdown, by Product Type 11.1.1.3.2 UK: Upstream Bioprocessing Market Breakdown, by Workflow 11.1.1.3.3 UK: Upstream Bioprocessing Market Breakdown, by Usage Type 11.1.1.3.4 UK: Upstream Bioprocessing Market Breakdown, by Mode 11.1.1.4 Germany 11.1.1.5 Germany: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million) 11.1.1.5.1 Germany: Upstream Bioprocessing Market Breakdown, by Product Type 11.1.1.5.2 Germany: Upstream Bioprocessing Market Breakdown, by Workflow 11.1.1.5.3 Germany: Upstream Bioprocessing Market Breakdown, by Usage Type 11.1.1.5.4 Germany: Upstream Bioprocessing Market Breakdown, by Mode 11.1.1.6 France 11.1.1.7 France: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million) 11.1.1.7.1 France: Upstream Bioprocessing Market Breakdown, by Product Type 11.1.1.7.2 France: Upstream Bioprocessing Market Breakdown, by Workflow 11.1.1.7.3 France: Upstream Bioprocessing Market Breakdown, by Usage Type 11.1.1.7.4 France: Upstream Bioprocessing Market Breakdown, by Mode 11.1.1.8 Italy 11.1.1.9 Italy: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million) 11.1.1.9.1 Italy: Upstream Bioprocessing Market Breakdown, by Product Type 11.1.1.9.2 Italy: Upstream Bioprocessing Market Breakdown, by Workflow 11.1.1.9.3 Italy: Upstream Bioprocessing Market Breakdown, by Usage Type 11.1.1.9.4 Italy: Upstream Bioprocessing Market Breakdown, by Mode 11.1.1.10 Spain 11.1.1.11 Spain: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million) 11.1.1.11.1 Spain: Upstream Bioprocessing Market Breakdown, by Product Type 11.1.1.11.2 Spain: Upstream Bioprocessing Market Breakdown, by Workflow 11.1.1.11.3 Spain: Upstream Bioprocessing Market Breakdown, by Usage Type 11.1.1.11.4 Spain: Upstream Bioprocessing Market Breakdown, by Mode 11.1.1.12 Rest of Europe 11.1.1.13 Rest of Europe: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million) 11.1.1.13.1 Rest of Europe: Upstream Bioprocessing Market Breakdown, by Product Type 11.1.1.13.2 Rest of Europe: Upstream Bioprocessing Market Breakdown, by Workflow 11.1.1.13.3 Rest of Europe: Upstream Bioprocessing Market Breakdown, by Usage Type 11.1.1.13.4 Rest of Europe: Upstream Bioprocessing Market Breakdown, by Mode 12. Industry Landscape 12.1 Overview 12.2 Growth Strategies in Upstream Bioprocessing Market 12.3 Organic Growth Strategies 12.3.1 Overview 12.4 Inorganic Growth Strategies 12.4.1 Overview 13. Company Profiles 13.1 Thermo Fisher Scientific Inc 13.1.1 Key Facts 13.1.2 Business Description 13.1.3 Products and Services 13.1.4 Financial Overview 13.1.5 SWOT Analysis 13.1.6 Key Developments 13.2 Esco Micro Pte Ltd 13.2.1 Key Facts 13.2.2 Business Description 13.2.3 Products and Services 13.2.4 Financial Overview 13.2.5 SWOT Analysis 13.2.6 Key Developments 13.3 Cellexus International Ltd 13.3.1 Key Facts 13.3.2 Business Description 13.3.3 Products and Services 13.3.4 Financial Overview 13.3.5 SWOT Analysis 13.3.6 Key Developments 13.4 Sartorius AG 13.4.1 Key Facts 13.4.2 Business Description 13.4.3 Products and Services 13.4.4 Financial Overview 13.4.5 SWOT Analysis 13.4.6 Key Developments 13.5 Getinge AB 13.5.1 Key Facts 13.5.2 Business Description 13.5.3 Products and Services 13.5.4 Financial Overview 13.5.5 SWOT Analysis 13.5.6 Key Developments 13.6 Merck KGaA 13.6.1 Key Facts 13.6.2 Business Description 13.6.3 Products and Services 13.6.4 Financial Overview 13.6.5 SWOT Analysis 13.6.6 Key Developments 13.7 Corning Inc 13.7.1 Key Facts 13.7.2 Business Description 13.7.3 Products and Services 13.7.4 Financial Overview 13.7.5 SWOT Analysis 13.7.6 Key Developments 13.8 Entegris Inc 13.8.1 Key Facts 13.8.2 Business Description 13.8.3 Products and Services 13.8.4 Financial Overview 13.8.5 SWOT Analysis 13.8.6 Key Developments 14. Appendix 14.1 About The Insight Partners 14.2 Glossary of Terms
ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。本レポートと同分野(映画・娯楽)の最新刊レポートThe Insight Partners 社の最新刊レポート
本レポートと同じKEY WORD(media)の最新刊レポート
よくあるご質問The Insight Partners社はどのような調査会社ですか?The Insight Partnersはインドに本社を置く調査会社です。経験豊富な専門家チームを通じて、お客様に最適な調査と分析を提供することに専念しています。幅広い分野をカバーしていますがヘルスケ... もっと見る 調査レポートの納品までの日数はどの程度ですか?在庫のあるものは速納となりますが、平均的には 3-4日と見て下さい。
注文の手続きはどのようになっていますか?1)お客様からの御問い合わせをいただきます。
お支払方法の方法はどのようになっていますか?納品と同時にデータリソース社よりお客様へ請求書(必要に応じて納品書も)を発送いたします。
データリソース社はどのような会社ですか?当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
|
詳細検索
2024/10/22 10:26 151.74 円 164.56 円 199.74 円 |